PROS1 and COVID-19: Herein, we employed peptide microarray technology and a Luminex-based assay along with serum samples retrieved from COVID-19 patients, COVID-19 naïve individuals (pre-pandemic samples) and a set of certified standard COVID-19 plasma samples to profile linear B-cell epitopes of SARS-CoV-2 S protein and define highly discriminatory epitopes.